Effect of estradiol on plasma melatonin levels

Area of Science:

• Endocrinology
• Chronobiology
• Reproductive Science

Background:

• Melatonin, a hormone regulating sleep-wake cycles, exhibits episodic secretion patterns.
• Estradiol (E2), a primary female sex hormone, has known effects on endocrine function.
• Previous research in nonhuman animals suggested E2 administration would increase melatonin levels.

Purpose of the Study:

• To investigate the effect of estradiol valerate (E2) administration on melatonin, testosterone, and estradiol levels in a normal adult male.
• To observe the pattern of melatonin secretion over a 4-hour period.
• To compare the observed hormonal response to E2 with existing data from nonhuman animal models.

Main Methods:

• Plasma samples collected every 15 minutes over 4 hours (08:00-12:00) for 5 consecutive days.
• Estradiol valerate (10 micrograms/kg) administered at the end of sampling periods on days 1-3.
• Analysis of melatonin, testosterone, and estradiol levels in plasma samples.

Main Results:

• An episodic pattern of melatonin secretion was confirmed.
• Following E2 administration, mean estradiol levels significantly increased.
• Mean melatonin and testosterone levels significantly decreased post-E2 administration.

Conclusions:

• Estradiol administration in normal adult males can lead to a significant decrease in melatonin and testosterone levels.
• This observed decrease in melatonin contradicts the expected response based on nonhuman animal experimental data.
• The findings highlight a potential sex-specific difference in the endocrine response to estradiol.